Načítá se...

Discovery of MK-5046, a Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of Obesity

[Image: see text] We report the development and characterization of compound 22 (MK-5046), a potent, selective small molecule agonist of BRS-3 (bombesin receptor subtype-3). In pharmacological testing using diet-induced obese mice, compound 22 caused mechanism-based, dose-dependent reductions in foo...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Sebhat, Iyassu K., Franklin, Christopher, Lo, Michael M.-C., Chen, David, Jewell, James P., Miller, Randy, Pang, Jianmei, Palyha, Oksana, Kan, Yanqing, Kelly, Theresa M., Guan, Xiao-Ming, Marsh, Donald J., Kosinski, Jennifer A., Metzger, Joseph M., Lyons, Kathryn, Dragovic, Jasminka, Guzzo, Peter R., Henderson, Alan J., Reitman, Marc L., Nargund, Ravi P., Wyvratt, Matthew J., Lin, Linus S.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Chemical Society 2010
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4018145/
https://ncbi.nlm.nih.gov/pubmed/24900253
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ml100196d
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!